Carregant...
P08.55 δ-catenin modulates bevacizumab-induced glioma invasion
Introduction: Data showing that bevacizumab in combination with temozolomide and radiotherapy improved progression-free survival in patients with newly diagnosed glioblastoma have highlighted the potential of bevacizumab as a glioma therapy. However, while bevacizumab potently suppresses angiogenesi...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464067/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.244 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|